Devang Prajapati

Devang Prajapati is an Associate Clinical Professor in the Gastroenterology department at the University of California San Francisco (UCSF) and serves as a Gastroenterologist at the Veterans Affairs Central California Healthcare System (VA-VACCHCS). His clinical and research work focuses on gastroenterology, hepatology, and internal medicine, particularly in the context of inflammatory bowel disease (IBD), aspirin use, COVID-19, and gastrointestinal complications.

• Education:
  • B.Sc. in Biochemistry from University of Toronto (1991)
  • MD from University of Toronto (1995)
  • Internship and Residency in Internal Medicine at University of Toronto (1996-1999)
  • Fellowship in Gastroenterology/Hepatology at Medical College of Wisconsin (2002)
  • Advanced Therapeutic Endoscopy Training at Medical College of Wisconsin (2001)

Dr. Prajapati's research interests span clinical outcomes in gastrointestinal diseases, pharmacological interventions, and epidemiological studies. He has contributed to understanding the impact of aspirin on inflammatory bowel disease, COVID-19-related gastrointestinal complications, and acute pancreatitis outcomes. His 15 most recent publications (2021-2024) focus on gastroenterology, medicine, and diagnostic imaging, with subfields including inflammatory bowel disease, acute pancreatitis, ischemic colitis, hepatocellular carcinoma, and therapeutic endoscopy.

• Scientific Awards:
  • 2002: Trainee Research Award, 1st Place (Population Science, Medical College of Wisconsin Cancer Center)
  • 2004: Nominated for Healing Hands Award (Veterans Affairs Central California Healthcare System)
  • 2005: Certificate of Recognition (American College of Gastroenterology)
  • 2016: Presidential Poster Award (University of California San Francisco-Fresno)
  • 2017: 2nd Place, Resident Research Day